An overview on the current status of cancer nanomedicines.

Authors:
Dr. Mohammad Oves, Phd
Dr. Mohammad Oves, Phd
King Abdul Aziz University
Assistent Prof.
Microbiology
Jeddah, Makkah | Saudi Arabia
Mr Firoz CK, MSc MLT
Mr Firoz CK, MSc MLT
King Abdulaziz University
LECTURER
Jeddah | Saudi Arabia

Curr Med Res Opin 2018 05 22;34(5):911-921. Epub 2018 Jan 22.

a King Fahd Medical Research Center , King Abdulaziz University , Jeddah , Saudi Arabia.

Purpose: Cancer remains a significant cause of morbidity and mortality across the globe. A recent report suggests around 14.1 million new cases and 8.2 million cancer-related deaths, which are expected to reach 21.7 million and 13 million by 2030 worldwide, respectively.

Materials And Methods: Because of highly complex mechanisms of cancer progression, it is important to explore and develop new innovative technologies which are more efficient compared with presently available treatment options.

Results: Currently, chemotherapy, radiation and surgery are the most commonly used cancer treatment methods. In the last decade, nanomedicine emerged as an alternative treatment option that uses specific drug-delivery systems, improves efficacy of drugs and reduces detrimental side effects to normal tissues.

Conclusion: In this review, we have summarized cancer nanomedicines (active and passive drug delivery) available in the market. We have also discussed other nanomedicines that are at different stages of clinical trials.

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2017.1421528DOI Listing
May 2018
7 Reads
2.653 Impact Factor

Publication Analysis

Top Keywords

cancer nanomedicines
8
cancer
5
cancer treatment
4
treatment methods
4
commonly cancer
4
radiation surgery
4
surgery commonly
4
methods decade
4
decade nanomedicine
4
treatment option
4
alternative treatment
4
emerged alternative
4
nanomedicine emerged
4
chemotherapy radiation
4
optionsresults currently
4
develop innovative
4
explore develop
4
progression explore
4
cancer progression
4
innovative technologies
4

References

(Supplied by CrossRef)

Jabir NR et al.
Int J Nanomedicine 2012

Similar Publications